109 related articles for article (PubMed ID: 37852344)
1. Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors.
Drake KA; Talantov D; Tong GJ; Lin JT; Verheijden S; Katz S; Leung JM; Yuen B; Krishna V; Wu MJ; Sutherland AM; Short SA; Kheradpour P; Mumbach MR; Franz KM; Trifonov V; Lucas MV; Merson J; Kim CC;
Clin Immunol; 2023 Nov; 256():109808. PubMed ID: 37852344
[TBL] [Abstract][Full Text] [Related]
2. Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 Progressors.
Drake KA; Talantov D; Tong GJ; Lin JT; Verheijden S; Katz S; Leung JM; Yuen B; Krishna V; Wu MJ; Sutherland A; Short SA; Kheradpour P; Mumbach M; Franz K; Trifonov V; Lucas MV; Merson J; Kim CC;
bioRxiv; 2023 May; ():. PubMed ID: 37292797
[TBL] [Abstract][Full Text] [Related]
3. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study.
Hu Z; van der Ploeg K; Chakraborty S; Arunachalam PS; Mori DAM; Jacobson KB; Bonilla H; Parsonnet J; Andrews JR; Holubar M; Subramanian A; Khosla C; Maldonado Y; Hedlin H; de la Parte L; Press K; Ty M; Tan GS; Blish C; Takahashi S; Rodriguez-Barraquer I; Greenhouse B; Butte AJ; Singh U; Pulendran B; Wang TT; Jagannathan P
Elife; 2022 Oct; 11():. PubMed ID: 36239699
[TBL] [Abstract][Full Text] [Related]
4. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients.
Diray-Arce J; Fourati S; Doni Jayavelu N; Patel R; Maguire C; Chang AC; Dandekar R; Qi J; Lee BH; van Zalm P; Schroeder A; Chen E; Konstorum A; Brito A; Gygi JP; Kho A; Chen J; Pawar S; Gonzalez-Reiche AS; Hoch A; Milliren CE; Overton JA; Westendorf K; ; Cairns CB; Rouphael N; Bosinger SE; Kim-Schulze S; Krammer F; Rosen L; Grubaugh ND; van Bakel H; Wilson M; Rajan J; Steen H; Eckalbar W; Cotsapas C; Langelier CR; Levy O; Altman MC; Maecker H; Montgomery RR; Haddad EK; Sekaly RP; Esserman D; Ozonoff A; Becker PM; Augustine AD; Guan L; Peters B; Kleinstein SH
Cell Rep Med; 2023 Jun; 4(6):101079. PubMed ID: 37327781
[TBL] [Abstract][Full Text] [Related]
5. Multi-omic and comparative analyses revealed monocyte-derived alpha-defensin-1 correlated with COVID-19 severity and inhibited SARS-CoV-2 infection.
Qian X; Wu B; Chen X; Peng H; Liu M; Tang H; Xu Z; Xu C; Qi Z
J Med Virol; 2023 Jun; 95(6):e28845. PubMed ID: 37254949
[TBL] [Abstract][Full Text] [Related]
6.
Viurcos-Sanabria R; Manjarrez-Reyna AN; Solleiro-Villavicencio H; Rizo-Téllez SA; Méndez-García LA; Viurcos-Sanabria V; González-Sanabria J; Arroyo-Valerio A; Carrillo-Ruíz JD; González-Chávez A; León-Pedroza JI; Flores-Mejía R; Rodríguez-Cortés O; Escobedo G
Front Immunol; 2022; 13():897995. PubMed ID: 35860236
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes.
Uranga-Murillo I; Morte E; Hidalgo S; Pesini C; García-Mulero S; Sierra JL; Santiago L; Arias M; De Miguel D; Encabo-Berzosa MDM; Gracia-Tello B; Sanz-Pamplona R; Martinez-Lostao L; Galvez EM; Paño-Pardo JR; Ramirez-Labrada A; Pardo J
Theranostics; 2022; 12(1):290-306. PubMed ID: 34987646
[TBL] [Abstract][Full Text] [Related]
8. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
Front Immunol; 2019; 10():2849. PubMed ID: 31867010
[No Abstract] [Full Text] [Related]
9. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
Front Immunol; 2021; 12():746021. PubMed ID: 35082777
[TBL] [Abstract][Full Text] [Related]
10. Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals.
Chattopadhyay P; Khare K; Kumar M; Mishra P; Anand A; Maurya R; Gupta R; Sahni S; Gupta A; Wadhwa S; Yadav A; Devi P; Tardalkar K; Joshi M; Sethi T; Pandey R
Front Immunol; 2022; 13():1034159. PubMed ID: 36532041
[TBL] [Abstract][Full Text] [Related]
11. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
12. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.
You M; Chen L; Zhang D; Zhao P; Chen Z; Qin EQ; Gao Y; Davis MM; Yang P
Nat Cell Biol; 2021 Jun; 23(6):620-630. PubMed ID: 34108657
[TBL] [Abstract][Full Text] [Related]
13. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.
Romano A; Parrinello NL; Barchitta M; Manuele R; Puglisi F; Maugeri A; Barbato A; Triolo AM; Giallongo C; Tibullo D; La Ferla L; Botta C; Siragusa S; Iacobello C; Montineri A; Volti GL; Agodi A; Palumbo GA; Di Raimondo F
Sci Rep; 2022 May; 12(1):7237. PubMed ID: 35508575
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity.
MacCann R; Leon AAG; Gonzalez G; Carr MJ; Feeney ER; Yousif O; Cotter AG; de Barra E; Sadlier C; Doran P; Mallon PW
Front Immunol; 2023; 14():1166574. PubMed ID: 37261339
[TBL] [Abstract][Full Text] [Related]
15. A systematic meta-analysis of immune signatures in patients with COVID-19.
Liu K; Yang T; Peng XF; Lv SM; Ye XL; Zhao TS; Li JC; Shao ZJ; Lu QB; Li JY; Liu W
Rev Med Virol; 2021 Jul; 31(4):e2195. PubMed ID: 34260780
[TBL] [Abstract][Full Text] [Related]
16. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.
Wilk AJ; Lee MJ; Wei B; Parks B; Pi R; Martínez-Colón GJ; Ranganath T; Zhao NQ; Taylor S; Becker W; ; Jimenez-Morales D; Blomkalns AL; O'Hara R; Ashley EA; Nadeau KC; Yang S; Holmes S; Rabinovitch M; Rogers AJ; Greenleaf WJ; Blish CA
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34128959
[TBL] [Abstract][Full Text] [Related]
17. Dual activation profile of monocytes is associated with protection in Mexican patients during SARS-CoV-2 disease.
Acosta-Altamirano G; Garduño-Javier E; Hernández-Gómez V; Espinosa JA; Vaca-Paniagua F; Rodríguez-Sosa M; Juárez-Avelar I; Terrazas LI; Bravata-Alcántara JC; Sierra-Martínez M; Olguín JE
Appl Microbiol Biotechnol; 2022 Dec; 106(23):7905-7916. PubMed ID: 36342507
[TBL] [Abstract][Full Text] [Related]
18. Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity.
Berentschot JC; Drexhage HA; Aynekulu Mersha DG; Wijkhuijs AJM; GeurtsvanKessel CH; Koopmans MPG; Voermans JJC; Hendriks RW; Nagtzaam NMA; de Bie M; Heijenbrok-Kal MH; Bek LM; Ribbers GM; van den Berg-Emons RJG; Aerts JGJV; Dik WA; Hellemons ME
Front Immunol; 2023; 14():1254899. PubMed ID: 37881427
[TBL] [Abstract][Full Text] [Related]
19. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.
Byeon SK; Madugundu AK; Garapati K; Ramarajan MG; Saraswat M; Kumar-M P; Hughes T; Shah R; Patnaik MM; Chia N; Ashrafzadeh-Kian S; Yao JD; Pritt BS; Cattaneo R; Salama ME; Zenka RM; Kipp BR; Grebe SKG; Singh RJ; Sadighi Akha AA; Algeciras-Schimnich A; Dasari S; Olson JE; Walsh JR; Venkatakrishnan AJ; Jenkinson G; O'Horo JC; Badley AD; Pandey A
Lancet Digit Health; 2022 Sep; 4(9):e632-e645. PubMed ID: 35835712
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients.
Tembhare PR; Sriram H; Chatterjee G; Khanka T; Gokarn A; Mirgh S; Rajendra A; Chaturvedi A; Ghogale SG; Deshpande N; Girase K; Dalvi K; Rajpal S; Patkar N; Trivedi B; Joshi A; Murthy V; Shetty N; Nair S; More A; Kamtalwar S; Chavan P; Bhat V; Bhat P; Subramanian PG; Gupta S; Khattry N
Immunol Cell Biol; 2022 Jan; 100(1):61-73. PubMed ID: 34582592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
